🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in the Netherlands / NCT07586839
Recruiting Not applicable

Effect of a Nutritional Supplement on Muscle Recovery

NCT07586839 · tracked via the Priya Life Science Netherlands tracker
Phase
Not applicable
Started
2025-09-26
Last updated
2026-05-14

Condition(s) studied

Healthy

Investigational drug(s) / intervention(s)

Control drinkVegan supplement containing caprylic acid and omega-3 fatty acids

Control drink: Seven day supplementation with a muscle damaging exercise performed on day four

Vegan supplement containing caprylic acid and omega-3 fatty acids: Seven day supplementation with a muscle damaging exercise performed on day four

Study summary

The aim is to develop a food supplement drink that supports muscle health by combining specific fatty acids, which can positively affect metabolic and inflammation processes that are important for muscle health.

Eligibility

Sex
MALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Young (≥18 and ≤35 years) * Male sex * Non-obese (≥18.5 and ≤27.5 kg/m2) * Recreationally active (performing non-competitive exercise at least one time a week for minimally 30 minutes) Exclusion Criteria: * Smoking * Participation in structural exercise with a major eccentric component (e.g. soccer, basketball, trail running, etc…) * Chronic use of any prescribed over the counter pharmaceuticals * Any history of medical or surgical events that may effect the study outcomes * Following a specific diet (e.g. weight loss, ketogenic, vegan) * Taking protein supplements

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Wageningen University and Research Wageningen Gelderland Recruiting

More Wageningen University trials in the Netherlands

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07586839 on ClinicalTrials.gov ↗ ← All trials in the Netherlands